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Abstract____The effect of positional change of the carbonyl group of enamides on 
Bu3SnH-mediated alkyl radical cyclization leading to five-, six-, seven-, and eight-membered 
nitrogen-containing heterocycles was examined.  A 5-exo cyclization is generally preferred 
over a 6-endo ring closure in systems having an alkyl radical center on the enamide-acyl side 
chain, whereas enamides having an alkyl radical center opposite to the acyl side chain 
predominantly gave 6-endo cyclization products.  These results suggest that the exo or endo 
selectivity of radical cyclization onto the alkenic bond of enamides can be controlled by 
positional change of the carbonyl group.  For an understanding of these selectivities, heat of 
formation for each transition state was calculated.  6-Endo-selective radical cyclization was 
applied to the radical cascade, enabling a concise synthesis of a cylindricine skeleton.  A 7- 
or 8-endo alkyl radical cyclization, however, predominated over a corresponding 6- or 7-exo 
ring closure regardless of the positional change of the carbonyl group of enamides.     
___________________________________________________________________________ 
 
1.  Introduction 
In recent years, radical cyclization has emerged as a valuable tool for the construction of 
carbo- and heterocyclic compounds, including natural products.1  It has been recognized that 
a 5-exo cyclization is generally preferred over a 6-endo ring closure in systems having an 
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alkenic bond at the 5-position relative to the radical center.  For example, enamide 1, upon 
treatment with Bu3SnH in the presence of azobis(cyclohexanecarbonitrile) (ACN), 































Scheme 1.  
 
Formation of 2 was of particular interest since the primary alkyl radical 3 was formed from 1 
as an intermediate, though 6-endo cyclization of 1 might produce the more stable secondary 
α-acylamino radical 4.  We previously reported, however, that similar treatment of enamide 
5 exclusively gave the 6-endo cyclization product 6 (Scheme 1).3  We also found that 
enamide 7 predominantly gave the 6-exo cyclization product 8, whereas enamide 10 afforded 
the 7-endo cyclization product 11 (Scheme 2).4  These results strongly suggest that exo and 
endo selectivities of radical cyclization onto the alkenic bond of enamides can be controlled 
by positional change of the carbonyl group. 






























Scheme 2.  
 
In this paper, we describe the effect of positional change of the carbonyl group of enamides 
on the mode of Bu3SnH-mediated alkyl radical cyclization leading to five-, six-, seven-, and 
eight-membered nitrogen-containing heterocycles.  An application of the 6-endo-selective 
cyclization to a concise synthesis of a cylindricine skeleton is also described.5
 
2. Results and discussion 
2.1. 5-Exo versus 6-endo alkyl radical cyclizations onto enamide 
Condensation of butylamine and acetaldehyde followed by treatment of the resulting imine 
with acryloyl chloride and successive treatment with diphenyl diselenide/sodium borohydride 
gave enamide 12 (Scheme 3).  Treatment of enamide 12 with Bu3SnH in the presence of 
ACN in boiling toluene resulted in alkyl radical cyclization of enamide 12 to afford the 5-exo 
cyclization product 136 in 78% yield.  On the other hand, similar treatment of enamide 14, 
prepared from 3-(phenylseleno)propylamine and acetaldehyde, gave the 6-endo cyclization 
product 157 (61%) along with the 5-exo cyclization product 168 (29%).  Similar treatment of 
enamide 17 exclusively afforded the 5-exo cyclization product 18, whereas enamide 19 gave 
the 6-endo cyclization product 209 (73%) as a 1.5:1 mixture of trans and cis-isomers, along 
with a small quantity of the 5-exo cyclization product 21 (15%).  13C NMR spectra of 18 and 
21 showed the presence of a quaternary carbon atom at 64.0 and 66.3 ppm, respectively.  
These results clearly indicated that the mode of alkyl radical cyclization of enamides could be 
altered by changing the position of the carbonyl group of the enamides as in the cases of 






































































Scheme 3.  
 
Enamide 22, which was prepared from the corresponding ethyl ester, underwent acyl radical 
cyclization to afford also the 6-endo cyclization product 23 (97%) as a 1:1.5 mixture of trans 
and cis isomers.10 
 
2.2. Calculation of heat of formation for transition state 
For a better understanding of cyclization modes of 12, 14, 17, and 19, heat of formation for 
each transition state (TS) was calculated by using 6-31G*.11  First, alkyl radical cyclization of 
model radical A was computed for the exclusive formation of 5-exo compound 13 from 
enamide 12 (Fig. 1).  TS B was estimated to be more stable than TS C by ca. 4 kcal/mol, 
probably because TS B forms an ideal trajectory angle for radical approach to the double bond.  
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The planarity of the amide bond makes TS C a half-chair form which may result in 
considerable strain (see Supplementary data).  The reason for the exclusive formation of 
5-exo cyclization product 18 from 17 may be similar to that for the formation of 13.  
Calculation of TSs for cyclization of model radical D revealed that TS E for 5-exo cyclization 
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Figure 1.  
 
Since the energy difference between TS H and TS J is only ca 0.3 kcal/mol, both 5-exo 
cyclization product 16 and 6-endo cyclization product 15 can be formed by cyclization of 
radical G (Fig. 2).  In contrast to TS C, TS J (and also K) providing 15 is a chair-type 
transition state.  The predominance of 15 might be partially due to the contribution of 
thermodynamic control (stabilities of product radicals).11c  The product radical J’ was 
calculated to be ca 39 kcal/mol more stable than TS J, whereas radical H’ was estimated to be 


















ΔE = +3.18 kcal/mol




















α = 98.5° α = 99.1°
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ΔE = -31.20 kcal/mol ΔE = -38.70 kcal/mol
Figure 2.  
 
Calculation of TSs M-P for cyclization of radical L generated from 19 was also conducted (Fig. 
3).   Among them, TS O giving 6-endo cyclization product 20 exhibited the lowest heat of 
formation, and this supports the main formation of the 6-endo product 20.  Perhaps owing to 
non-bonded interaction, the trajectory angles in M and N are different from ideal ones.  For 
the formation of 5-exo cyclization product 21, the entropy effect might contribute to the 
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Figure 3.  
  
2.3. Synthesis of cyclindricine skeleton using endo-selective cyclizations 
The radical cascade consisting of 6-endo-trig and 5-endo-trig cyclizations was next 
examined.12  Treatment of enamide 24, prepared by bromination of the corresponding 
alcohol, with Bu3SnH/ACN afforded the cis-fused tricyclic compound 2513 in 30% yield 
(Scheme 4).  The structure of 25 was confirmed by an X-ray crystallographic analysis of the 
picrate 26 (CCDC 262989) prepared by reduction of 25 with borane.  Enamide 27, which 
was prepared by the corresponding ethyl ester, also gave the cis-fused compound 28 in 37% 
yield, the structure of which was again confirmed by an X-ray crystallographic analysis 
(CCDC 262990).  Compound 28 is a basic structural element of cylindricines, which cause 






































1) BH3 • THF
2) picric acid
quant.
X = Cl: cylindricine A
X = OH: cylindricine C
X = OMe: cylindricine D
X = OAc: cylindricine E
X = SCN: cylindricine F
 
 
The stereochemical outcome of the formation of the cis-fused compounds 25 and 28 from 24 
and 27, respectively, can be explained by assuming their transition state for the cyclizations.  
As depicted in Figure 4, two transition states Q and R may be considered for the final step 
(5-endo-trig) of the radical cascade.  The A ring of Q which provides 25 and 28 is a chair 
form and that of R leading to the trans-fused isomers 29 and 30 is a boat form.  The 
5-endo-trig cyclization may proceed through transition state Q, in which the A ring has a 
more favorable chair form, to give the observed cis-fused compound 25 or 28.  Indeed, 
calculation of TS Q and R (transition state geometry by using 3-21G* followed by single 















X = H2, O
25: X = H2







29: X = H2
30: X = O
Figure 4.
Q
 ² E = 0.00 kcal/mol
         (X = H2)
² E = +5.89 kcal/mol









2.4.  6-Exo versus 7-endo and 7-exo versus 8-endo alkyl radical cyclizations onto 
enamide 
Treatment of enamide 31 with Bu3SnH/ACN afforded the 7-endo alkyl radical cyclization 
product 32 in 77% yield as a 1:1 mixture of trans and cis stereoisomers (Scheme 5).  No 
expected 6-exo cyclization product was obtained.  On the other hand, similar treatment of 
enamide 34 afforded the expected 7-endo cyclization product 35 in 73% yield as a 1:5.7 
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trans : cis = 1 : 1
 
 
We further examined the mode of radical cyclization of enamides 37 and 40.  Enamide 37 
afforded the 8-endo cyclization product 38 (11%) along with the simple reduction product 39 
 
9
(46%) (Scheme 6).  No 7-exo cyclization product was formed.16  Enamide 40 gave the 
8-endo cyclization product 41, but in low yield (7%) along with a considerable amount of the 
simple reduction product 42 (84%).17  Exo and endo selectivities were no longer observed 
for the alkyl radical cyclization of enamides 31, 34, 37 and 40 having an alkenic bond at the 6 
or 7-position relative to the radical center.  This was probably associated with an increase in 


































Scheme 6.  
 
The aryl radical cyclization of enamide 7 gave the 6-exo cyclization product 8 in a high 
selectivity with reduction of the entropy effect (Scheme 2), and therefore the cyclization of 43 
was examined in the hope that this compound might result in the selective formation of a 
7-exo cyclization product.  Enamide 43 was prepared by treatment of 
N-ethyl-N-[2-(phenylthio)ethyl]-o-bromophenylpropionamide with m-chloroperbenzoic acid 
(mCPBA) followed by thermolysis of the resulting sulfoxide.  Treatment of 43 with 
Bu3SnH/ACN afforded the expected 7-exo cyclization product 44, but in low yield (6%) 




























We revealed that the 5-exo and 6-endo selectivity for alkyl radical cyclization onto the alkenic 
bond of enamide could be controlled by positional change of the carbonyl group.  
Calculation of heat of formation for each transition state (TS) supported these observations.  
6-Endo-selective cyclization was applied to the radical cascade involving 5-endo trig 
cyclization, giving a concise synthesis of a cylindricine skeleton.  A 7- or 8-endo alkyl 
radical cyclization predominated over a corresponding 6- or 7-exo cyclization regardless of 
the positional change of the carbonyl group of enamide.  This was probably due to an 
increase in the entropy effect.  An application of the endo-selective cyclization to the radical 
cascade would be highly promising in natural products synthesis.  The results will be 
reported in due course. 
 
4.  Experimental 
4.1.  General.  
Melting points are uncorrected.  Infrared (IR) spectra were recorded on a Shimadzu FTIR-8100 
spectrophotometer for solutions in CHCl3.  1H NMR and 13C NMR spectra were measured on a 
JEOL EX 500 (500 MHz) or a JEOL JNM-EX 270 (270 MHz) spectrometer.  Chemical shifts 
(δ) quoted are relative to tetramethylsilane.  High resolution mass spectra (HRMS) were 
obtained with a JEOL JMS-SX-102A mass spectrometer.  Column chromatography was 
carried out on silica gel 60N (Kanto Kagaku Co., Ltd., spherical, neutral, 63–210 μm) under 
pressure. 
4.1.1.  3-Bromo-N-cyclohex-1-en-1-yl-N-ethylpropanamide (17).  To a solution of 
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cyclohexanone (785 mg, 8.00 mmol) in toluene (5 mL) was bubbled ethylamine at -78 ˚C for 5 
min, and the mixture was heated in sealed tube at 110 ˚C for 2.5 h.  After excess ethylamine 
was removed under reduced pressure, THF (10 mL), NaHCO3 (1.00 g, 12.0 mmol) and 
3-bromopropionyl chloride (1.37 g, 8.00 mmol) were added to the residue at 0 ˚C, and the 
mixture was stirred at room temperature for 30 min.  The reaction mixture was diluted with 
water and extracted with AcOEt. The organic phase was washed brine, dried (MgSO4), and 
concentrated. The residue was chromatographed on silica gel (benzene/Et2O, 6:1) to give 17 
(95.0 mg, 5%) as a colorless oil: IR (CHCl3) υ 1635 cm-1; 1H NMR (270 MHz, CDCl3) δ 1.11 
(3H, t, J = 7.1 Hz), 1.57-1.66 (2H, m), 1.71-1.79 (2H, m), 2.05-2.19 (4H, m), 2.85 (2H, t, J = 
6.9 Hz), 3.35-3.55 (2H, m), 3.64 (2H, t, J = 6.9 Hz), 5.61-5.64 (1H, m); 13C NMR (67.8 MHz, 
CDCl3) δ 13.2, 21.42, 22.7, 24.7, 28.11, 28.13, 36.7, 40.3, 128.0, 137.8, 168.6.  Anal. Calcd 
for C11H18BrNO: C, 50.78; H, 6.97; N, 5.38. Found: C, 50.91; H, 7.16; N, 5.56. 
4.1.2.  1-Ethyl-1-azaspiro[4.5]decan-2-one (18).  General procedure for radical reaction.  
To a boiling solution of 17 (90.0 mg, 0.346 mmol) in toluene (25 mL) was added dropwise a 
solution of Bu3SnH (151 mg, 0.519 mmol) and ACN (17.0 mg, 0.0692 mmol) in toluene (25 
mL) over 3 h and the mixture was further heated at reflux for 1 h.  After evaporation of the 
solvent, the residue was chromatographed on silica gel containing KF (10%)18 (hexane/AcOEt, 
2:1) to give 18 (66.0 mg, 100%) as a colorless oil: IR (CHCl3) υ 1665 cm-1; 1H NMR (270 
MHz, CDCl3) δ 1.03-1.13 (1H, m), 1.15 (3H, t, J = 7.3 Hz), 1.25-1.76 (9H, m), 1.89 (2H, t, J = 
8.1 Hz), 2.34 (2H, t, J = 8.1 Hz), 3.19 (2H, q, J = 7.3 Hz); 13C NMR (67.8 MHz, CDCl3) 
δ  15.3, 22.9, 25.0, 29.0, 29.3, 33.9, 35.3, 64.0, 174.3; HRMS calcd for C11H19NO 181.1467, 
Found: 181.1471.  
4.1.3.  N-(3-Bromopropyl)-N-cyclohex-1-en-1-ylacetamide (19). A mixture of 
3-(tert-butyldimethylsilyloxy)propylamine19 (2.50 g, 13.2 mmol) and cyclohexanone (1.30 g, 
13.2 mmol) in benzene (30 mL) was heated under reflux with azeotropic removal of water for 
1.5 h.  Triethylamine (2.40 g, 23.8 mmol) and acetyl chloride (1.55 g, 19.8 mmol) were 
added at 0 °C, and the mixture was stirred at room temperature for 20 min.  The reaction 
mixture was washed with brine, dried (MgSO4), and concentrated. THF (50 mL) was added to 
the residue, a 1.0 M solution of tetrabutylammonium fluoride in THF (16 mL, 15.8 mmol) was 
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added to this solution, and the mixture was stirred at room temperature for 1 h.  The reaction 
mixture was diluted with water and extracted with EtOAc, and the organic layer was washed 
with brine, dried (MgSO4) and concentrated. The residue was chromatographed on silica gel 
(hexane/AcOEt, 1:1) to give N-cyclohex-1-en-1-yl-N-(3-hydroxypropyl)acetamide (1.40 g, 
54%) as a colorless oil: IR (CHCl3) υ 1625 cm-1; 1H NMR (270 MHz, CDCl3) δ 1.57-1.81 (6H, 
m), 2.05 (3H, s), 2.07-2.17 (4H, m), 3.52-3.56 (4H, m), 4.12 (1H, br), 5.56-5.58 (1H, m); 13C 
NMR (67.8 MHz, CDCl3) δ 21.26, 21.33, 22.6, 24.6, 27.4, 30.4, 41.2, 58.0, 127.8, 138.6, 
171.4.  Anal. Calcd for C11H19NO2･1/5H2O: C, 65.77; H, 9.73; N, 6.97. Found: C, 65.79; H, 
9.88; N, 6.98. 
To a solution of N-cyclohex-1-en-1-yl-N-(3-hydroxypropyl)acetamide (500 mg, 2.53 mmol) 
and triethylamine (617 mg, 6.08 mmol) in toluene (10 mL) was added a solution of 
methanesulfonyl chloride (348 mg, 3.04 mmol) in toluene (10 mL) at 0 ˚C, and the mixture 
was stirred at the same temperature for 1 h. The reaction mixture was washed with brine, dried 
(MgSO4), and concentrated.  DMF (10 mL) and LiBr (2.20 g, 25.3 mmol) were added to the 
residue and the mixture was stirred at room temperature for 3 h.  The reaction mixture was 
diluted with water and extracted with Et2O.  The organic layer was washed with brine, dried 
(MgSO4), and concentrated.  The residue was chromatographed on silica gel (hexane/AcOEt, 
4:1) to give 19 (392 mg, 60%) as a colorless oil: IR (CHCl3) υ 1680 cm-1; 1H NMR (270 MHz, 
CDCl3) δ 1.57-1.65 (2H, m), 1.71-1.79 (2H, m), 2.01 (3H, s), 2.05-2.17 (6H, m), 3.41 (2H, t, J 
= 7.0 Hz), 3.50 (2H, t, J = 7.3 Hz), 5.59-5.63 (1 H, m).  It was used in the next step without 
further purification. 
4.1.4.  1-Acetyldecahydroquinoline (20) and 1-acetyl-1-azaspiro[4.5]decane (21).  
Following the general procedure, a boiling solution of 19 (150 mg, 0.577 mmol) in toluene (40 
mL) was treated with a solution of Bu3SnH (249 mg, 0.865 mmol) and ACN (28.0 mg, 0.115 
mmol) in toluene (40 mL).  After work-up, the residue was chromatographed on silica gel 
containing KF (10%) (hexane/AcOEt, 4:1).  The first eluent gave 21 (15.3 mg, 15%) as a 
colorless needles, mp 95-96 ˚C (hexane): IR (CHCl3) υ 1625 cm-1; 1H NMR (270 MHz, 
CDCl3) δ  1.23-1.33 (4H, m), 1.57-1.91 (8H, m), 2.01 (3H, s), 2.61-2.73 (2H, m), 3.44 (2H, t, J 
= 6.6 Hz); 13C NMR (67.8 MHz, CDCl3) δ  23.0, 24.5, 25.3, 25.5, 33.2, 36.3, 49.9, 66.3, 
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169.2; HRMS calcd for C11H19NO 181.1467, found: 181.1475.  The second eluent gave a 
mixture of two stereoisomers (trans/cis = 1.5:1) of 20 (76.5 mg, 73%) as a colorless oil: IR 
(CHCl3) υ 1620 cm-1; 1H NMR (270 MHz, CDCl3) δ 1.00-1.89 [(12 + 2/5)H, m], 2.05-2.12 
(3/5H, m), 2.07 (3H x 4/5, s), 2.10 (3H x 1/5, s), 2.57 (1/5H, td, J = 13.3, 2.6 Hz), 3.04-3.33 
[(1 + 2/5)H, m], 3.53-3.74 (1H, m), 4.47-4.53 (1/5H, m), 4.63 (1/5H, dt, J = 12.5, 3.8 Hz); 
HRMS calcd for C11H19NO 181.1467, found: 181.1471.  1H NMR spectral data of 20 were 
identical with those reported in the literature.9    
4.1.5.  Se-Phenyl N-acryloyl-3-(cyclohex-1-en-1-ylamino)selenopropanoate (27).  Using 
a procedure similar to that described for the preparation of 19, β-alanine ethyl ester 
hydrochloride (3.00 g, 19.5 mmol) was condensed with cyclohexanone (9.47 g, 97.7 mmol) 
and the mixture was treated with acryloyl chloride (2.67 g, 29.3 mmol) and triethylamine (3.56 
g, 35.2 mmol).  After work-up, the crude material was chromatographed (hexane/AcOEt, 
6:1) to give ethyl N-acryloyl-3-(cyclohex-1-en-1-ylamino)propanoate (2.30 g, 47%) as a 
colorless oil: IR (CHCl3) υ 1730, 1645, 1615 cm-1; 1H NMR (270 MHz, CDCl3) δ 1.22 (3H, t, 
J = 7.3 Hz), 1.53-1.61 (2H, m), 1.67-1.75 (2H, m), 1.99-2.10 (4H, m), 2.55 (2H, t, J = 7.3 Hz), 
3.73 (2H, t, J = 7.3 Hz), 4.09 (2H, q, J = 7.3 Hz), 5.53-5.57 (2H, m), 6.29 (1H, dd, J = 16.8, 
3.0 Hz), 6.41 (1H, dd, J = 16.8, 9.6 Hz); 13C NMR (67.8 MHz, CDCl3) δ 14.1, 21.4, 22.6, 24.8, 
28.0, 33.0, 41.3, 60.4, 127.0, 128.37, 128.43, 137.8, 165.1, 171.7.  Anal. Calcd for 
C14H21NO3: C, 66.91; H, 8.42; N, 5.57. Found: C, 66.85; H, 8.52; N, 5.19. 
Ethyl N-acryloyl-3-(N-cyclohex-1-en-1-ylamimo)propanoate (1.13 g, 4.48 mmol) was 
hydrolyzed with NaOH (2 mL), and the resulting carboxylic acid was treated with sodium 
hydride (60% oil suspension, 214 mg, 5.37mmol) to give sodium salt of the corresponding 
carboxylic acid.  Diphenyl diselenide (2.80 g, 8.96 mmol) and tributylphosphine (1.81 g, 8.96 
mmol) in THF (20 mL) were added to the solution at room temperature, and the mixture was 
stirred for 3 h.20  To the reaction mixture was added sodium benzoate (1.94 g, 13.4 mmol), 
and the mixture was further stirred for 10 min.  Phenylselenenyl chloride (1.72 g, 13.4 mmol) 
was added to the solution and the mixture was stirred for 1 h.  The reaction mixture was 
diluted with a saturated aqueous solution of NaHCO3 and extracted with AcOEt.  The organic 
phase was washed with brine, dried (MgSO4) and concentrated.  The residue was 
 
14
chromatographed on silica gel (benzene/Et2O, 6:1) to give 27 (641 mg, 40%) as a colorless oil: 
IR (CHCl3) υ 1715, 1645, 1610 cm-1; 1H NMR (270 MHz, CDCl3) δ 1.55-1.64 (2H, m), 
1.68-1.77 (2H, m) 2.07-2.17 (4H, m), 3.02 (2H, t, J = 7.3 Hz), 3.80 (2H, t, J = 7.3 Hz), 
5.58-5.63 (2H, m), 6.34 (1H, dd, J = 16.8, 3.0 Hz), 6.44 (1H, dd, J = 16.8, 9.2 Hz), 7.33-7.43 
(3H, m), 7.46-7.52 (2H, m); 13C NMR (67.8 MHz, CDCl3) δ 21.3, 22.6, 24.8, 28.0, 41.3, 45.8, 
126.1, 127.3, 128.2, 128.8, 128.9, 129.3, 135.7, 137.7, 165.3, 198.5; HRMS (FAB) calcd for 
C18H22NO2Se (MH+) 364.0816, found 364.0822. 
4.1.6.  (7aR*,11aR*)-hexahydro-1H-pyrrolo[2,1-j]quinoline-3,7(2H,7aH)-dione (28).  
Following the general procedure, a boiling solution of 27 (530 mg, 1.46 mmol) in toluene (70 
mL) was treated with a solution of Bu3SnH (649 mg, 2.20 mmol) and ACN (71.5 mg, 0.292 
mmol) in toluene (70 mL).  After work-up, the residue was chromatographed on silica gel 
containing KF (10%) (hexane/AcOEt, 1:1) to give 28 (113 mg, 37%) as colorless crystals, mp 
106-107 ˚C (hexane): IR (CHCl3) υ 1715, 1680 cm-1; 1H NMR (500 MHz, C6D6) δ 0.76-1.88 
(2H, m), 0.92 (1H, tt, J = 13.4, 3.7 Hz), 1.02 (1H, td, J = 13.4, 3.7 Hz), 1.17-1.28 (3H, m), 
1.31-1.42 (3H, m), 1.83 (1H, td, J = 14.0 and 7.9 Hz), 1.91 (1H, dd, J = 14.7, 4.3 Hz), 2.03 
(2H, t, J = 7.3 Hz), 2.10-2.15 (1H, m), 2.49 (1H, td, 13.4 and 3.7 Hz), 4.26 (1H, ddd, 13.4, 7.9, 
1.8 Hz): 13C NMR (67.8 MHz, CDCl3) δ 20.5, 21.7, 22.3, 29.0, 29.4, 32.4, 35.0, 39.7, 55.2, 
64.6, 173.1, 207.3.  Anal. Calcd for C12H17NO2: C, 69.54, 8.27, N, 6.76. Found: C, 69.31, H, 
8.42, N, 6.61. 
4.1.7. 1-Ethyldecahydro-2H-1-benzazepin-2-one (32) and 
N-cyclohex-1-en-1-yl-N-ethylbutanamide (33).  Following the general procedure, a boiling 
solution of 31 (180 mg, 0.346 mmol) in toluene (30 mL) was treated with a solution of 
Bu3SnH (286 mg, 0.984 mmol) and ACN (32.0 mg, 0.131 mmol) in toluene (30 mL).  After 
work-up, the residue was chromatographed on silica gel containing KF (10%) (hexane/AcOEt, 
1:1).  The first eluent gave 33 (30.0 mg, 23%) as a colorless oil: IR (CHCl3) υ 1630 cm-1; 1H 
NMR (270 MHz, CDCl3) δ 0.91 (3H, t, J = 7.4 Hz), 1.15 (3H, t, J = 7.3 Hz), 1.60-1.78 (6H, 
m), 2.07-2.18 (4H, m), 2.22 (2H, t, J = 7.3 Hz), 3.42-3.63 (2H, m), 5.57-5.59 (1H, m); 13C 
NMR (67.8 MHz, CDCl3) δ 13.4, 13.9, 19.2, 21.6, 22.8, 24.7, 28.3, 35.5, 40.2, 127.1, 138.5, 
172.0; HRMS calcd for C12H21NO 195.1623, Found: 195.1622.  The second eluent gave 32 
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(98.0 mg, 77%) as a colorless oil: IR (CHCl3) υ 1615 cm-1; 1H NMR (500 MHz, CDCl3) δ 1.12 
(3H x 1/2, t, J = 7.1 Hz), 1.13 (3H x 1/2, t, J = 7.1 Hz), 1.25-2.04 (13H, m), 2.42 (1/2H, t, J = 
13.9 Hz), 2.53 (1/2H, ddd, J = 14.6, 10.0, 3.9 Hz), 2.58 (1/2H, dd, J = 14.6, 7.3 Hz), 2.75 
(1/2H, ddd, J = 15.1, 9.8, 5.1 Hz), 3.18 (1/2H, dt, J = 13.0, 3.2 Hz), 3.21 (1/2H, dq, J = 13.9, 
7.1 Hz), 3.27 (1/2H, td, J = 11.2, 3.2 Hz), 3.32 (1/2H, dq, J = 13.9, 7.1 Hz), 3.45 (1/2H, dq, J 
= 13.9, 7.1 Hz), 3.68 (1/2H, dq, J = 13.9, 7.1 Hz); 13C NMR (67.8 MHz, CDCl3) δ 13.4, 14.9, 
16.2, 19.8, 23.5, 25.8, 26.1, 26.7, 27.2, 29.5, 29.6, 30.3, 31.0, 34.1, 34.3, 36.2, 38.4, 39.1, 40.4, 
44.7, 60.9, 63.2, 173.2, 174.6; HRMS calcd for C12H21NO 195.1623, Found: 195.1629. 
4.1.8.  (6aR*,10aS*)-1-Ethyldodecahydro-1-benzazocin-2(1H)-one (38) and 
N-cyclohex-1-en-1-yl-N-ethylpentanamide (39).  Following the general procedure, a 
boiling solution of 37 (200 mg, 0.694 mmol) in toluene (30 mL) was treated with a solution of 
Bu3SnH (303 mg, 1.04 mmol) and ACN (34.0 mg, 0.139 mmol) in toluene (30 mL).  After 
work-up, the residue was chromatographed on silica gel containing KF (10%) (hexane/AcOEt, 
2:1).  The first eluent gave 39 (67.0 mg, 46%) as a colorless oil: IR (CHCl3) υ 1625 cm-1; 1H 
NMR (270 MHz, CDCl3) δ 0.90 (3H, t, J = 7.3 Hz), 1.09 (3H, t, J = 7.3 Hz), 1.31 (2H, sextet, 
J = 7.3 Hz), 1.57-1.79 (6 H, m), 2.06-2.15 (4H, m), 2.24 (2H, t, J = 7.4 Hz), 3.39-3.47 (2H, m), 
5.57-5.60 (1H, m); 13C NMR (67.8 MHz, CDCl3) δ 13.4, 13.8, 21.6, 22.5, 22.8, 24.7, 28.1, 
28.3, 33.3, 40.2, 127.1, 138.5, 172.4; HRMS calcd for C13H23NO 209.1780, Found: 209.1773.  
The second eluent gave 38 (16.0 mg, 11%) as a colorless oil: IR (CHCl3) υ 1615 cm-1; 1H 
NMR (270 MHz, CDCl3) δ 1.14 (3H, t, J = 7.1 Hz), 1.22-1.94 (15H, m), 2.37 (1H, ddd, J = 
13.2, 5.9, 2.0 Hz), 2.61 (1H, td, J = 13.0, 2.5 Hz), 2.97 (1H, dq, J = 13.8, 7.1 Hz), 3.49 (1H, td, 
J = 10.4, 3.5 Hz), 3.58 (1H, dq, J = 13.8, 7.1 Hz); 13C NMR (67.8 MHz, CDCl3) δ 15.0, 22.3, 
25.7, 26.1, 29.4, 30.3, 30.9, 31.2, 35.5, 36.0, 41.2, 59.3, 174.6; HRMS calcd for C13H23NO 
209.1780, Found: 209.1776. 
4.1.9.  2-Ethyl-1-methyl-1,2,4,5-tetrahydro-3H-2-benzazepin-3-one (44), 
3-ethyl-2,3,5,6-tetrahydro-3-benzazocin-4(1H)-one (45) and  
N-ethenyl-N-ethyl-3-phenylpropanamide (46).  Following the general procedure, a boiling 
solution of 43 (150 mg, 0.531 mmol) in toluene was treated with a solution of Bu3SnH (232 
mg, 0.794 mmol) and ACN (26.0 mg, 0.106 mmol) in toluene.  After work-up, the crude 
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material was chromatographed on silica gel containing KF (10%) (hexane/AcOEt, 1:1).  The 
first eluent gave 46 (86.2 mg, 80%) as a colorless oil.  1H NMR and 13C NMR spectra of 46 
showed it to contain two rotamers: IR (CHCl3) υ 1620, 1665 cm-1; 1H NMR (270 MHz, 
CDCl3) δ 1.12 (3 H, t, J = 7.1 Hz), 2.73 (2 H, t, J = 7.3 Hz), 2.99 (2 H, t, J = 7.3 Hz), 3.53 (2H 
x 1/4, q, J = 7.1 Hz), 3.70 (2H x 3/4, q, J = 7.1 Hz), 4.31 (3/4H, d, J = 9.2 Hz), 4.42 (1/4H, d, J 
= 9.2 Hz), 4.46 (1/4H, d, J = 15.3 Hz), 4.48 (3/4H, d, J = 15.3 Hz), 6.74 (3/4H, dd, J = 15.3, 
9.2 Hz), 7.20-7.40 (5H, m), 7.45 (1/4 H, dd, J = 15.3, 9.2 Hz); 13C NMR (67.8 MHz, CDCl3) δ 
11.8, 12.8, 21.9, 24.3, 31.0, 33.8, 35.7, 36.7, 93.1, 93.4, 126.1, 128.3, 128.4, 130.8, 132.1, 
140.9, 170.3; HRMS calcd for C13H17NO 203.1310, found: 203.1303.  The second eluent 
gave 44 (6.0 mg, 6%) as a colorless oil: IR (CHCl3) υ 1670, 1630 cm-1; 1H NMR (270 MHz, 
CDCl3) δ 1.11, 1.13 (total 3 H, t, J = 7.1 Hz), 1.25 (3 H x 9/20, d, J = 7.4 Hz), 1.52 (9/20H, dd, 
J = 6.6, 4.3 Hz), 1.71 (3 H x 11/20, d, J = 7.4 Hz), 2.54 (11/20H, dd, J = 16.8, 8.7 Hz), 
2.74-2.87 (1H, m), 2.93-3.14 [(2 + 11/20)H, m], 3.29-3.42 (11/20H, m), 3.60-3.77[(1 + 9/20)H, 
m], 4.63 (9/20H, q, J = 7.4 Hz), 7.09-7.37 (4H, m); 13C NMR (67.8 MHz, CDCl3) δ 12.7, 13.7, 
18.6, 23.6, 29.4, 34.9, 35.5, 39.1, 42.8, 46.8, 59.0, 60.7, 126.1, 127.1, 127.3, 128.28, 128.33, 
128.4, 128.5, 128.8, 130.6, 137.7, 139.4, 141.8, 173.1, 173.2; HRMS calcd for C13H17NO 
203.1310, Found: 203.1307.  The third eluent gave 45 (5.0 mg, 5%) as colorless oil: IR 
(CHCl3) υ 1630 cm-1; 1H NMR (270 MHz, CDCl3) δ 0.93 (3H, t, J = 7.1 Hz), 2.82-2.88 (2H, 
m), 2.97-3.08 (2H, m), 3.10 (2H, t, J = 6.8 Hz), 3.14 (2H, q, J = 7.1 Hz), 3.70 (2H, t, J = 6.8 
Hz), 7.02-7.31 (4H, m); 13C NMR (67.8 MHz, CDCl3) δ 12.7, 30.5, 34.7, 37.0, 41.5, 46.2, 
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